Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taylor Ngo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 8, 2024
Imaging Phospholipase D Activity with Clickable Alcohols via TransphosphatidylationShyamal P Waghwala, Taylor Ngo, Ainsely Verkaik
Frontiers in Genome Editing|October 29, 2021
CRISPR Technology for Ocular AngiogenesisSook Hyun Chung, Tzu-Ni Sin, Taylor Ngo, et al.
Clinical Genitourinary Cancer|July 7, 2014
Patient demographic characteristics and disease stage as drivers of disparities in mortality in prostate cancer patients who receive care at a safety net academic medical centerAlexander E Rand, Ankit Agarwal, Divya Ahuja, et al.
International Journal of Breast Cancer|November 26, 2015
Race/Ethnicity, Primary Language, and Income Are Not Demographic Drivers of Mortality in Breast Cancer Patients at a Diverse Safety Net Academic Medical CenterDivya A Parikh, Rani Chudasama, Ankit Agarwal, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 19, 2024
Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular DegenerationAbraham Hang, Taylor Ngo, Jaipreet Singh Virk, et al.
Human Gene Therapy|January 15, 2021
Host Immune Responses after Suprachoroidal Delivery of AAV8 in Nonhuman Primate EyesSook Hyun Chung, Iris Natalie Mollhoff, Alaknanda Mishra, et al.
Molecular Therapy. Nucleic Acids|May 26, 2022
CRISPR-based VEGF suppression using paired guide RNAs for treatment of choroidal neovascularizationSook Hyun Chung, Tzu-Ni Sin, Brian Dang, et al.
Pediatric Nephrology (Berlin, Germany)|August 1, 2022
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trialWesley Hayes, David J Sas, Daniella Magen, et al.
The International Journal of Biological Markers|September 28, 2012
Circulating tumor cells as predictors of response and failure in breast cancer patients treated with preoperative chemotherapyRimoun R Boutrus, Rita F Abi Raad, Irene Kuter, et al.
Kidney International Reports|March 8, 2022
Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1Sally A Hulton, Jaap W Groothoff, Yaacov Frishberg, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|July 8, 2024
Imaging Phospholipase D Activity with Clickable Alcohols via TransphosphatidylationShyamal P Waghwala, Taylor Ngo, Ainsely Verkaik
Frontiers in Genome Editing|October 29, 2021
CRISPR Technology for Ocular AngiogenesisSook Hyun Chung, Tzu-Ni Sin, Taylor Ngo, et al.
Clinical Genitourinary Cancer|July 7, 2014
Patient demographic characteristics and disease stage as drivers of disparities in mortality in prostate cancer patients who receive care at a safety net academic medical centerAlexander E Rand, Ankit Agarwal, Divya Ahuja, et al.
International Journal of Breast Cancer|November 26, 2015
Race/Ethnicity, Primary Language, and Income Are Not Demographic Drivers of Mortality in Breast Cancer Patients at a Diverse Safety Net Academic Medical CenterDivya A Parikh, Rani Chudasama, Ankit Agarwal, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 19, 2024
Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular DegenerationAbraham Hang, Taylor Ngo, Jaipreet Singh Virk, et al.
Human Gene Therapy|January 15, 2021
Host Immune Responses after Suprachoroidal Delivery of AAV8 in Nonhuman Primate EyesSook Hyun Chung, Iris Natalie Mollhoff, Alaknanda Mishra, et al.
Molecular Therapy. Nucleic Acids|May 26, 2022
CRISPR-based VEGF suppression using paired guide RNAs for treatment of choroidal neovascularizationSook Hyun Chung, Tzu-Ni Sin, Brian Dang, et al.
Pediatric Nephrology (Berlin, Germany)|August 1, 2022
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trialWesley Hayes, David J Sas, Daniella Magen, et al.
The International Journal of Biological Markers|September 28, 2012
Circulating tumor cells as predictors of response and failure in breast cancer patients treated with preoperative chemotherapyRimoun R Boutrus, Rita F Abi Raad, Irene Kuter, et al.
Kidney International Reports|March 8, 2022
Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1Sally A Hulton, Jaap W Groothoff, Yaacov Frishberg, et al.
Pageof 1